GSK Operating Metrics

Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.

GSK key operating metrics including Phase II Trials Products, environmental, and social and governance score (ESG).

Phase II Trials Products

14.3%

FY, 2021

Healthcare Products in Development

8.5%

FY, 2021

Phase I Trials Products

33.3%

FY, 2021

Operating Metrics

Metrics	FY, 2019	FY, 2020	FY, 2021
Phase II Trials Products	14	7	6
Healthcare Products in Development	39	59	64
Phase I Trials Products	12	12	16
Vaccine Doses Delivered per Day	2M
Vaccines	701M	580M	767M
Countries	95	96	92
Volume of Medicines Produced	2.3B	2.2B	1.7B
Consumer Healthcare Products Produced	4.2B	3.8B	3.7B
Phase III Trials Products	16	11	11
Suppliers		36K	37.5K

60-79 out of 100

Community

Employees

Environment

Governance

Premium Content only available in Craft’s Intelligence Portal

Source:CSRHub